Bacopasaponin CCAS# 178064-13-6 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 178064-13-6 | SDF | Download SDF |
| PubChem ID | 21599443 | Appearance | White powder |
| Formula | C46H74O17 | M.Wt | 899 |
| Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in ethanol and methanol; insoluble in chloroform and n-hexane | ||
| Chemical Name | None | ||
| SMILES | CC(=CC1COC23CC4(CO2)C(C3C1(C)O)CCC5C4(CCC6C5(CCC(C6(C)C)OC7C(C(C(CO7)O)OC8C(C(C(C(O8)CO)O)O)O)OC9C(C(C(O9)CO)O)O)C)C)C | ||
| Standard InChIKey | ZOFQVMPJZHCDBS-MUUHSGPCSA-N | ||
| Standard InChI | InChI=1S/C46H74O17/c1-21(2)14-22-17-57-46-19-45(20-58-46)23(37(46)44(22,7)55)8-9-28-42(5)12-11-29(41(3,4)27(42)10-13-43(28,45)6)61-40-36(63-38-33(53)31(51)26(16-48)60-38)35(24(49)18-56-40)62-39-34(54)32(52)30(50)25(15-47)59-39/h14,22-40,47-55H,8-13,15-20H2,1-7H3/t22-,23-,24+,25-,26+,27+,28-,29+,30-,31+,32+,33-,34-,35+,36-,37+,38+,39+,40+,42+,43-,44+,45+,46-/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Bacopasaponin C may have antioxidant activity. 2. Bacopasaponin C shows anti-leishmanial property. |
| Targets | NMDAR | GABA Receptor | Antifection |
Bacopasaponin C Dilution Calculator
Bacopasaponin C Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.1123 mL | 5.5617 mL | 11.1235 mL | 22.2469 mL | 27.8087 mL |
| 5 mM | 0.2225 mL | 1.1123 mL | 2.2247 mL | 4.4494 mL | 5.5617 mL |
| 10 mM | 0.1112 mL | 0.5562 mL | 1.1123 mL | 2.2247 mL | 2.7809 mL |
| 50 mM | 0.0222 mL | 0.1112 mL | 0.2225 mL | 0.4449 mL | 0.5562 mL |
| 100 mM | 0.0111 mL | 0.0556 mL | 0.1112 mL | 0.2225 mL | 0.2781 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Nociceptin (1-13)NH2
Catalog No.:BCC5749
CAS No.:178064-02-3
- Aescigenin
Catalog No.:BCC8293
CAS No.:17806-68-7
- Fmoc-D-Phe(4-NO2)-OH
Catalog No.:BCC3278
CAS No.:177966-63-1
- Allopurinol Sodium
Catalog No.:BCC4886
CAS No.:17795-21-0
- Sauchinone
Catalog No.:BCN2299
CAS No.:177931-17-8
- Clematichinenoside C
Catalog No.:BCN7850
CAS No.:177912-24-2
- Boc-His-OH
Catalog No.:BCC3398
CAS No.:17791-52-5
- Eletriptan HBr
Catalog No.:BCC5039
CAS No.:177834-92-3
- Calystegine A6
Catalog No.:BCN1886
CAS No.:177794-04-6
- Calystegine N1
Catalog No.:BCN1866
CAS No.:177794-03-5
- Proxyfan oxalate
Catalog No.:BCC7378
CAS No.:177708-09-7
- NKP608
Catalog No.:BCC1802
CAS No.:177707-12-9
- 3-Deoxyzinnolide
Catalog No.:BCN4799
CAS No.:17811-32-4
- H-Asp-OMe
Catalog No.:BCC2884
CAS No.:17812-32-7
- 6,7,4'-Trihydroxyisoflavone
Catalog No.:BCN2910
CAS No.:17817-31-1
- Hardwickiic acid
Catalog No.:BCN1132
CAS No.:1782-65-6
- Linderone
Catalog No.:BCN1133
CAS No.:1782-79-2
- Tetrahymanone
Catalog No.:BCN6932
CAS No.:17822-06-9
- Calystegine B3
Catalog No.:BCN1880
CAS No.:178231-95-3
- Orphanin FQ (1-11)
Catalog No.:BCC6085
CAS No.:178249-41-7
- Nociceptin (1-7)
Catalog No.:BCC5738
CAS No.:178249-42-8
- H-D-Asp-OH
Catalog No.:BCC2894
CAS No.:1783-96-6
- 12-Hydroxy-6-epi-albrassitriol
Catalog No.:BCN7460
CAS No.:178330-78-4
- Tos-Arg-OMe.HCl
Catalog No.:BCC2874
CAS No.:1784-03-8
Inhibitory effect of bacopasides on spontaneous morphine withdrawal induced depression in mice.[Pubmed:24243728]
Phytother Res. 2014 Jun;28(6):937-9.
Bacopa monnieri is a perennial herb with a world known image as a nootropic. We investigated the effect of Bacopa monnieri methanolic extract (Mt Ext BM) 10, 20, and 30 mg/kg body weight (b.w) on acquisition and expression of morphine withdrawal induced depression in mice. Locally available Bacopa monnieri (BM) was screened for contents of Bacoside A3, Bacopasaponin C, and Bacopaside II using HPLC with UV. Morphine dependence was induced in mice using twice daily escalating chronic morphine treatments (20-65 mg/kg b.w) for eight consecutive days. Morphine withdrawal induced depression was assayed in animals using forced swimming test (FST), three days after last morphine injection. The HPLC analysis revealed that Mt-ext BM contained Bacoside A3 as major component, i.e. 4 microg in each mg of extract. The chronic treatment with Met Ext BM 10, 20, and 30 mg/kg b.w. dosing significantly inhibited opioid withdrawal induced depression in mice. These findings imply a newer potential role of Bacopa monnieri in the clinical management of opioid withdrawal induced depression which can be attributed to Bacoside A3.
A Bacoside containing Bacopa monnieri extract reduces both morphine hyperactivity plus the elevated striatal dopamine and serotonin turnover.[Pubmed:22105846]
Phytother Res. 2012 May;26(5):758-63.
Bacopa monnieri (BM) has been used in Ayurvedic medicine as a nootropic, anxiolytic, antiepileptic and antidepressant. An n-butanol extract of the plant (nBt-ext BM) was analysed and found to contain Bacoside A (Bacoside A3, Bacopaside II and Bacopasaponin C). The effects of the BM extract were then studied on morphine-induced hyperactivity as well as dopamine and serotonin turnover in the striatum since these parameters have a role in opioid sensitivity and dependence. Mice were pretreated with saline or nBt-ext BM (5, 10 and 15 mg/kg, orally), 60 min before morphine administration and locomotor activity was subsequently recorded. Immediately after testing, striatal tissues were analysed for dopamine (DA), serotonin (5HT) and their metabolites using HPLC coupled with electrochemical detection. The results indicated that nBt-ext BM significantly (p < 0.001) decreased locomotor activity in both the saline and morphine treated groups. Additionally, nBt-ext BM significantly lowered morphine-induced dopamine (DA), dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA) and 5-hydroxyindole acetic acid (5-H1AA) upsurges in the striatum but failed to affect DA, 5-HT and their metabolites in the saline treated group. These findings suggest that nBt-ext BM has an antidopaminergic/serotonergic effect and may have potential beneficial effects in the treatment of morphine dependence.
